Reviewed by WANGYATAO·Last reviewed 2026-11-11·Medical disclaimer

In short

China's 2025 CAP guide updates severity assessment (CURB-65/CRB-65), empiric antibiotic selection by risk group, the role of biomarkers and rapid diagnostics, and step-down/community care to reduce unnecessary hospitalization.

What this guide covers: What is community-acquired pneumonia? · Diagnosis and severity · Antibiotic therapy · Supportive and follow-up care · For patients

What is community-acquired pneumonia?

CAP is lung infection acquired outside hospitals, presenting with cough, fever, sputum, and breathlessness. The 2025 China guide standardizes how it is recognized and treated across settings.

Diagnosis and severity

Chest imaging confirms pneumonia; severity scores (CURB-65/CRB-65) and biomarkers (CRP, procalcitonin) help decide inpatient versus outpatient care and antibiotic urgency. Atypical and viral causes are considered, especially in epidemics.

Antibiotic therapy

Outpatient low-risk patients often receive a respiratory fluoroquinolone or macrolide/beta-lactam; higher-risk cases use broader empiric coverage with de-escalation once cultures return. Duration is typically 5–7 days guided by clinical response.

Supportive and follow-up care

Oxygen, hydration, and bronchitis control support recovery. Follow-up imaging is not routinely needed if symptoms resolve.

For patients

Seek care promptly for high fever with breathlessness, especially if you are elderly or have chronic illness. Finish the prescribed antibiotic course.

Sources and further reading

One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.

General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.